Tumor necrosis factor antagonist responsiveness in a United States rheumatoid arthritis cohort.

Greenberg, Jeffrey D

Tumor necrosis factor antagonist responsiveness in a United States rheumatoid arthritis cohort. [electronic resource] - The American journal of medicine Jun 2008 - 532-8 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1555-7162

10.1016/j.amjmed.2008.02.018 doi


Adalimumab
Adult
Aged
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Arthritis, Rheumatoid--drug therapy
Cohort Studies
Etanercept
Female
Humans
Immunoglobulin G--therapeutic use
Infliximab
Male
Middle Aged
Multicenter Studies as Topic
Patient Selection
Randomized Controlled Trials as Topic
Receptors, Tumor Necrosis Factor--therapeutic use
Reproduction
Treatment Outcome
Tumor Necrosis Factor-alpha--antagonists & inhibitors
United States